Discovery of a novel rhein-SAHA hybrid as a multi-targeted anti-glioblastoma drug
{{output}}
Glioblastoma multiforme (GBM) is the most common malignant tumor of the central nervous system (CNS). Effective treatments remain limited. Therefore, novel chemotherapy drugs with high efficiency and few adverse effects are urgently needed. Histone deacetylase... ...
